TY - JOUR AU - Hanauer, S. B. AU - Feagan, B. G. AU - Lichtenstein, G. R. PY - 2002 DA - 2002// TI - Maintenance infliximab for Crohn’s disease: the ACCENT I randomised trial JO - Lancet VL - 359 UR - https://doi.org/10.1016/S0140-6736(02)08512-4 DO - 10.1016/S0140-6736(02)08512-4 ID - Hanauer2002 ER - TY - JOUR AU - Sandborn, W. J. AU - Hanauer, S. B. AU - Rutgeerts, P. PY - 2007 DA - 2007// TI - Adalimumab for maintenance treatment of Crohn’s disease: results of the CLASSIC II trial JO - Gut VL - 56 UR - https://doi.org/10.1136/gut.2006.106781 DO - 10.1136/gut.2006.106781 ID - Sandborn2007 ER - TY - JOUR AU - Rutgeerts, P. AU - Sandborn, W. J. AU - Feagan, B. G. PY - 2005 DA - 2005// TI - Infliximab for induction and maintenance therapy for ulcerative colitis JO - N Engl J Med VL - 353 UR - https://doi.org/10.1056/NEJMoa050516 DO - 10.1056/NEJMoa050516 ID - Rutgeerts2005 ER - TY - JOUR AU - Loftus, E. V. AU - Schoenfeld, P. AU - Sandborn, W. J. PY - 2002 DA - 2002// TI - The epidemiology and natural history of Crohn’s disease in population-based patient cohorts from North America: a systematic review JO - Aliment Pharmacol Ther VL - 16 UR - https://doi.org/10.1046/j.1365-2036.2002.01140.x DO - 10.1046/j.1365-2036.2002.01140.x ID - Loftus2002 ER - TY - JOUR AU - Cosnes, J. AU - Nion-Larmurier, I. AU - Beaugerie, L. PY - 2005 DA - 2005// TI - Impact of the increasing use of immunosuppressants in Crohn’s disease on the need for intestinal surgery JO - Gut VL - 54 UR - https://doi.org/10.1136/gut.2004.045294 DO - 10.1136/gut.2004.045294 ID - Cosnes2005 ER - TY - JOUR AU - Sands, B. E. AU - Arsenault, J. E. AU - Rosen, M. J. PY - 2003 DA - 2003// TI - Risk of early surgery for Crohn’s disease: implications for early treatment strategies JO - Am J Gastroenterol VL - 98 UR - https://doi.org/10.1111/j.1572-0241.2003.08674.x DO - 10.1111/j.1572-0241.2003.08674.x ID - Sands2003 ER - TY - JOUR AU - Farrell, R. J. AU - Alsahli, M. AU - Jeen, Y. -. T. PY - 2003 DA - 2003// TI - Intravenous hydrocortisone premedication reduces antibodies to infliximab in Crohn’s disease: a randomized controlled trial JO - Gastroenterology VL - 124 UR - https://doi.org/10.1053/gast.2003.50145 DO - 10.1053/gast.2003.50145 ID - Farrell2003 ER - TY - JOUR AU - Colombel, J. -. F. AU - Loftus, E. V. AU - Tremaine, W. J. PY - 2004 DA - 2004// TI - The safety profile of infliximab in patients with Crohn’s disease: the Mayo clinic experience in 500 patients JO - Gastroenterology VL - 126 UR - https://doi.org/10.1053/j.gastro.2003.10.047 DO - 10.1053/j.gastro.2003.10.047 ID - Colombel2004 ER - TY - JOUR AU - Hanauer, S. B. AU - Sandborn, W. J. AU - Rutgeerts, P. PY - 2006 DA - 2006// TI - Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn’s disease: the CLASSIC-I trial JO - Gastroenterology VL - 130 UR - https://doi.org/10.1053/j.gastro.2005.11.030 DO - 10.1053/j.gastro.2005.11.030 ID - Hanauer2006 ER - TY - JOUR AU - Ford, A. C. AU - Sandborn, W. J. AU - Khan, K. J. PY - 2011 DA - 2011// TI - Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis JO - Am J Gastroenterol VL - 106 UR - https://doi.org/10.1038/ajg.2011.73 DO - 10.1038/ajg.2011.73 ID - Ford2011 ER - TY - JOUR AU - Peyrin-Biroulet, L. AU - Bigard, M. -. A. AU - Malesci, A. AU - Danese, S. PY - 2008 DA - 2008// TI - Step-up and top-down approaches to the treatment of Crohn’s disease: early may already be too late JO - Gastroenterology VL - 135 UR - https://doi.org/10.1053/j.gastro.2008.08.017 DO - 10.1053/j.gastro.2008.08.017 ID - Peyrin-Biroulet2008 ER - TY - JOUR AU - Nuij, V. AU - Fuhler, G. M. AU - Edel, A. J. PY - 2015 DA - 2015// TI - Benefit of earlier anti-TNF treatment on IBD disease complications? JO - J Crohn’s Colitis VL - 9 UR - https://doi.org/10.1093/ecco-jcc/jjv130 DO - 10.1093/ecco-jcc/jjv130 ID - Nuij2015 ER - TY - JOUR AU - Limbergen, J. AU - Russell, R. K. AU - Nimmo, E. R. AU - Satsangi, J. PY - 2007 DA - 2007// TI - The genetics of inflammatory bowel disease JO - Am J Gastroenterol VL - 102 UR - https://doi.org/10.1111/j.1572-0241.2007.01527.x DO - 10.1111/j.1572-0241.2007.01527.x ID - Limbergen2007 ER - TY - JOUR AU - Orholm, M. AU - Fonager, K. AU - Sorensen, H. T. PY - 1999 DA - 1999// TI - Risk of ulcerative colitis and Crohn’s disease among offspring of patients with chronic inflammatory bowel disease JO - Am J Gastroenterol VL - 94 UR - https://doi.org/10.1111/j.1572-0241.1999.01526.x DO - 10.1111/j.1572-0241.1999.01526.x ID - Orholm1999 ER - TY - JOUR AU - Liu, J. Z. AU - Sommeren, S. AU - Huang, H. PY - 2015 DA - 2015// TI - Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations JO - Nat Genet VL - 47 UR - https://doi.org/10.1038/ng.3359 DO - 10.1038/ng.3359 ID - Liu2015 ER - TY - JOUR AU - Jostins, L. AU - Ripke, S. AU - Weersma, R. K. PY - 2012 DA - 2012// TI - Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease JO - Nature VL - 491 UR - https://doi.org/10.1038/nature11582 DO - 10.1038/nature11582 ID - Jostins2012 ER - TY - JOUR AU - Ek, W. E. AU - D’Amato, M. AU - Halfvarson, J. PY - 2014 DA - 2014// TI - The history of genetics in inflammatory bowel disease JO - Ann Gastroenterol VL - 27 ID - Ek2014 ER - TY - JOUR AU - Lees, C. W. AU - Barrett, J. C. AU - Parkes, M. AU - Satsangi, J. PY - 2011 DA - 2011// TI - New IBD genetics: common pathways with other diseases JO - Gut VL - 60 UR - https://doi.org/10.1136/gut.2009.199679 DO - 10.1136/gut.2009.199679 ID - Lees2011 ER - TY - JOUR AU - Deuring, J. J. AU - Fuhler, G. M. AU - Konstantinov, S. R. PY - 2014 DA - 2014// TI - Genomic ATG16L1 risk allele-restricted Paneth cell ER stress in quiescent Crohn’s disease JO - Gut ID - Deuring2014 ER - TY - JOUR AU - Parkes, M. PY - 2012 DA - 2012// TI - Evidence from genetics for a role of autophagy and innate immunity in IBD pathogenesis JO - Dig Dis VL - 30 UR - https://doi.org/10.1159/000338119 DO - 10.1159/000338119 ID - Parkes2012 ER - TY - JOUR AU - Fritz, T. AU - Niederreiter, L. AU - Adolph, T. PY - 2011 DA - 2011// TI - Crohn’s disease: NOD2, autophagy and ER stress converge JO - Gut VL - 60 UR - https://doi.org/10.1136/gut.2009.206466 DO - 10.1136/gut.2009.206466 ID - Fritz2011 ER - TY - JOUR AU - Knights, D. AU - Silverberg, M. S. AU - Weersma, R. K. PY - 2014 DA - 2014// TI - Complex host genetics influence the microbiome in inflammatory bowel disease JO - Genome Med VL - 6 UR - https://doi.org/10.1186/s13073-014-0107-1 DO - 10.1186/s13073-014-0107-1 ID - Knights2014 ER - TY - JOUR AU - Diegelmann, J. AU - Czamara, D. AU - Bras, E. PY - 2013 DA - 2013// TI - Intestinal DMBT1 expression is modulated by Crohn’s disease-associated IL23R variants and by a DMBT1 variant which influences binding of the transcription factors CREB1 and ATF-2 JO - PLoS ONE VL - 8 UR - https://doi.org/10.1371/journal.pone.0077773 DO - 10.1371/journal.pone.0077773 ID - Diegelmann2013 ER - TY - JOUR AU - Somasundaram, R. AU - Deuring, J. J. AU - Woude, C. J. PY - 2012 DA - 2012// TI - Linking risk conferring mutations in NCF4 to functional consequences in Crohn’s disease JO - Gut VL - 61 UR - https://doi.org/10.1136/gutjnl-2011-301344 DO - 10.1136/gutjnl-2011-301344 ID - Somasundaram2012 ER - TY - JOUR AU - Lennard-Jones, J. E. PY - 1989 DA - 1989// TI - Classification of inflammatory bowel disease JO - Scand J Gastroenterol VL - 24 UR - https://doi.org/10.3109/00365528909091339 DO - 10.3109/00365528909091339 ID - Lennard-Jones1989 ER - TY - JOUR AU - Satsangi, J. AU - Silverberg, M. S. AU - Vermeire, S. AU - Colombel, J. -. F. PY - 2006 DA - 2006// TI - The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications JO - Gut VL - 55 UR - https://doi.org/10.1136/gut.2005.082909 DO - 10.1136/gut.2005.082909 ID - Satsangi2006 ER - TY - JOUR AU - Kaser, A. AU - Lee, A. -. H. AU - Franke, A. PY - 2008 DA - 2008// TI - XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease JO - Cell VL - 134 UR - https://doi.org/10.1016/j.cell.2008.07.021 DO - 10.1016/j.cell.2008.07.021 ID - Kaser2008 ER - TY - JOUR AU - Tschurtschenthaler, M. AU - Adolph, T. E. AU - Ashcroft, J. W. PY - 2017 DA - 2017// TI - Defective ATG16L1-mediated removal of IRE1α drives Crohn’s disease-like ileitis JO - J Exp Med VL - 214 UR - https://doi.org/10.1084/jem.20160791 DO - 10.1084/jem.20160791 ID - Tschurtschenthaler2017 ER - TY - JOUR AU - Pidasheva, S. AU - Trifari, S. AU - Phillips, A. PY - 2011 DA - 2011// TI - Functional studies on the IBD susceptibility gene IL23R implicate reduced receptor function in the protective genetic variant R381Q JO - PLoS ONE VL - 6 UR - https://doi.org/10.1371/journal.pone.0025038 DO - 10.1371/journal.pone.0025038 ID - Pidasheva2011 ER - TY - JOUR AU - Ito, T. AU - Carson, W. F. AU - Cavassani, K. A. PY - 2011 DA - 2011// TI - CCR6 as a mediator of immunity in the lung and gut JO - Exp Cell Res VL - 317 UR - https://doi.org/10.1016/j.yexcr.2010.12.018 DO - 10.1016/j.yexcr.2010.12.018 ID - Ito2011 ER - TY - JOUR AU - Jung, C. AU - Colombel, J. -. F. AU - Lemann, M. PY - 2012 DA - 2012// TI - Genotype/phenotype analyses for 53 Crohn’s disease associated genetic polymorphisms JO - PLoS ONE VL - 7 UR - https://doi.org/10.1371/journal.pone.0052223 DO - 10.1371/journal.pone.0052223 ID - Jung2012 ER - TY - JOUR AU - Barrett, J. C. AU - Hansoul, S. AU - Nicolae, D. L. PY - 2008 DA - 2008// TI - Genome-wide association defines more than 30 distinct susceptibility loci for Crohn’s disease JO - Nat Genet VL - 40 UR - https://doi.org/10.1038/ng.175 DO - 10.1038/ng.175 ID - Barrett2008 ER - TY - JOUR AU - Takazoe, M. AU - Matsui, T. AU - Motoya, S. PY - 2009 DA - 2009// TI - Sargramostim in patients with Crohn’s disease: results of a phase 1–2 study JO - J Gastroenterol VL - 44 UR - https://doi.org/10.1007/s00535-009-0029-7 DO - 10.1007/s00535-009-0029-7 ID - Takazoe2009 ER - TY - JOUR AU - Korzenik, J. R. AU - Dieckgraefe, B. K. PY - 2005 DA - 2005// TI - An open-labelled study of granulocyte colony-stimulating factor in the treatment of active Crohn’s disease JO - Aliment Pharmacol Ther VL - 21 UR - https://doi.org/10.1111/j.1365-2036.2005.02287.x DO - 10.1111/j.1365-2036.2005.02287.x ID - Korzenik2005 ER - TY - JOUR AU - Korzenik, J. R. AU - Dieckgraefe, B. K. AU - Valentine, J. F. PY - 2005 DA - 2005// TI - Sargramostim for active Crohn’s disease JO - N Engl J Med VL - 352 UR - https://doi.org/10.1056/NEJMoa041109 DO - 10.1056/NEJMoa041109 ID - Korzenik2005 ER - TY - JOUR AU - Pena-Rossi, C. AU - Schreiber, S. AU - Golubovic, G. PY - 2008 DA - 2008// TI - Clinical trial: a multicentre, randomized, double-blind, placebo-controlled, dose-finding, phase II study of subcutaneous interferon-beta-la in moderately active ulcerative colitis JO - Aliment Pharmacol Ther VL - 28 UR - https://doi.org/10.1111/j.1365-2036.2008.03778.x DO - 10.1111/j.1365-2036.2008.03778.x ID - Pena-Rossi2008 ER - TY - JOUR AU - Rossi, C. P. AU - Hanauer, S. B. AU - Tomasevic, R. PY - 2009 DA - 2009// TI - Interferon beta-1a for the maintenance of remission in patients with Crohn’s disease: results of a phase II dose-finding study JO - BMC Gastroenterol VL - 9 UR - https://doi.org/10.1186/1471-230X-9-22 DO - 10.1186/1471-230X-9-22 ID - Rossi2009 ER - TY - JOUR AU - Jakobsen, C. AU - Cleynen, I. AU - Andersen, P. S. PY - 2014 DA - 2014// TI - Genetic susceptibility and genotype–phenotype association in 588 Danish children with inflammatory bowel disease JO - J Crohns Colitis VL - 8 UR - https://doi.org/10.1016/j.crohns.2013.12.010 DO - 10.1016/j.crohns.2013.12.010 ID - Jakobsen2014 ER - TY - JOUR AU - Cleynen, I. AU - John, J. M. M. AU - Henckaerts, L. PY - 2010 DA - 2010// TI - Molecular reclassification of Crohn’s disease by cluster analysis of genetic variants JO - PLoS ONE VL - 5 UR - https://doi.org/10.1371/journal.pone.0012952 DO - 10.1371/journal.pone.0012952 ID - Cleynen2010 ER - TY - JOUR AU - Wagner, J. AU - Sim, W. H. AU - Ellis, J. A. PY - 2010 DA - 2010// TI - Interaction of Crohn’s disease susceptibility genes in an Australian paediatric cohort JO - PLoS ONE VL - 5 UR - https://doi.org/10.1371/journal.pone.0015376 DO - 10.1371/journal.pone.0015376 ID - Wagner2010 ER - TY - JOUR AU - Plantinga, T. S. AU - Crisan, T. O. AU - Oosting, M. PY - 2011 DA - 2011// TI - Crohn’s disease-associated ATG16L1 polymorphism modulates pro-inflammatory cytokine responses selectively upon activation of NOD2 JO - Gut VL - 60 UR - https://doi.org/10.1136/gut.2010.228908 DO - 10.1136/gut.2010.228908 ID - Plantinga2011 ER - TY - JOUR AU - Plantinga, T. S. AU - Joosten, L. A. B. AU - Netea, M. G. PY - 2011 DA - 2011// TI - ATG16L1 polymorphisms are associated with NOD2-induced hyperinflammation JO - Autophagy VL - 7 UR - https://doi.org/10.4161/auto.7.9.15867 DO - 10.4161/auto.7.9.15867 ID - Plantinga2011 ER - TY - JOUR AU - Ellinghaus, D. AU - Bethune, J. AU - Petersen, B. -. S. AU - Franke, A. PY - 2015 DA - 2015// TI - The genetics of Crohn’s disease and ulcerative colitis—status quo and beyond JO - Scand J Gastroenterol VL - 50 UR - https://doi.org/10.3109/00365521.2014.990507 DO - 10.3109/00365521.2014.990507 ID - Ellinghaus2015 ER - TY - JOUR PY - 2007 DA - 2007// TI - Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls JO - Nature VL - 447 UR - https://doi.org/10.1038/nature05911 DO - 10.1038/nature05911 ID - ref44 ER - TY - JOUR AU - Cleynen, I. AU - Vermeire, S. PY - 2015 DA - 2015// TI - The genetic architecture of inflammatory bowel disease: past, present and future JO - Curr Opin Gastroenterol VL - 31 ID - Cleynen2015 ER - TY - JOUR AU - Rioux, J. D. AU - Xavier, R. J. AU - Taylor, K. D. PY - 2007 DA - 2007// TI - Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis JO - Nat Genet. VL - 39 UR - https://doi.org/10.1038/ng2032 DO - 10.1038/ng2032 ID - Rioux2007 ER -